Clinical Trial Update: The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update evaluating a synbiotics supplement on lipid profile, liver enzymes, inflammatory markers, and hepatic fibrosis in lean a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Synbiotics supplement (Synbiotics)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Non Alcoholic Steatohepatitis | Phase 2, Phase 3 | Status: UNKNOWN